NUS · XBRL financial data

Nu Skin Enterprises financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (NUS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	2,582	2,696	2,226	1,969	1,732	1,485
Cost of goods and services sold	658	675	631	612	550	454
Gross profit	1,924	2,020	1,595	1,357	1,182	1,031
Research and development	23	27	23	23	13	11
General and administrative	647	666	556	547	479	432
Total operating expenses	1,666	1,786	1,484	1,309	1,333	966
Operating income (loss)	258	234	111	48	(152)	66
Interest expense	13	11	14	26	26	14
Income tax expense (benefit)	65	85	(16)	18	(28)	36
Net income (loss)	191	147	105	9	(147)	160
Earnings per share, basic USD per share	3.66	2.93	2.10	0.17	(2.95)	3.25
Earnings per share, diluted USD per share	3.63	2.86	2.07	0.17	(2.95)	3.18
Weighted average shares, basic millions of shares	52	50	50	50	50	49
Weighted average shares, diluted millions of shares	53	51	51	50	50	50

Fiscal years (NUS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	403	340	265	256	187	239
Short-term investments	21	15	14	12	11	1
Accounts receivable	63	41	47	73	51	40
Inventory	314	400	346	280	190	179
Prepaid and other current assets	102	77	88	81	73	90
Total current assets	903	873	760	702	539	548
Property and equipment, net	468	454	445	433	380	377
Right-of-use asset	155	121	99	90	73	74
Goodwill	203	206	206	231	84	84
Total assets	1,957	1,906	1,821	1,806	1,469	1,405
Accounts payable	66	50	54	44	35	26
Accrued liabilities	447	372	280	260	218	218
Current portion of long-term debt	30	108	25	25	30	20
Total current liabilities	543	530	359	329	297	264
Long-term debt	305	269	377	478	364	204
Lease liability, non-current	112	89	77	71	58	58
Total liabilities	1,063	994	924	984	817	600
Retained earnings	1,841	1,912	1,939	1,870	1,712	1,860
Total stockholders' equity	894	913	897	822	651	805
Total liabilities and equity	1,957	1,906	1,821	1,806	1,469	1,405
Common shares outstanding (cover page) millions of shares	51	50	49	49	50	48

Fiscal years (NUS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	191	147	105	9	(147)	160
Stock-based compensation	24	23	12	16	15	24
Depreciation and amortization	74	76	73	71	70	52
Net cash from operating activities	379	142	108	119	112	80
Purchases of property and equipment	64	69	59	58	42	34
Net cash from investing activities	(79)	(89)	(67)	(135)	(38)	171
Share repurchases	144	80	70	13	0	20
Dividends paid	78	76	77	78	12	12
Proceeds from long-term debt	115	155	460	110	15	55
Repayments of long-term debt	143	115	433	10	125	225
Net cash from financing activities	(245)	(105)	(100)	11	(133)	(202)
Net change in cash	67	(63)	(75)	(9)	(69)	52

SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Nu Skin Enterprises	190	320	11*	48.7M	—	Q2 FY26 10-QJun 30, 2026
Herbalife	409	1,350	151*	104.9M	—	Q3 FY26 10-QSep 30, 2026
DataMeds AIadded: same SIC	2.5	1.8	(2.9)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Cosmos Healthadded: same SIC	1.8	19	(1.7)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtechadded: same SIC	0.2	0.6	(0.1)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
Cencoraadded: same SIC	2,815	84,755	2,654*	190.8M	—	Q3 FY26 10-QJun 30, 2026
Sharing Services Globaladded: same SIC	0.7	2.1	(0.4)*	309,652	1.7 quarters	Q2 FY25 10-QSep 30, 2024
Cardinal Healthadded: same SIC	4,856	year only	year only	232.6M	—	Q4 FY26 10-KJun 30, 2026
HWH Internationaladded: same SIC	1.5	0.1	0.5*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.